Axel Polack is 10% at CONCERT PHARMACEUTICALS, INC. (CNCE). They have made 1 open-market trade across 1 company since 2014, most recently 2014-02-19.
CIK 0001579076
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.2M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CNCE | BUY | 2014-02-19 | 2014-02-20 | $14.00 | $1.2M | -10.5% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.